Evidence map›Paper›PMID 35433129›Full record

ArticlePeerJ2022

A model of multiple tumor marker for lymph node metastasis assessment in colorectal cancer: a retrospective study.

Jiangping Fu, Mengjie Tu, Yin Zhang, Yan Zhang, Jiasi Wang, Zhaoping Zeng, Jie Li, Fanxin Zeng

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jiangping Fu *Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.
Mengjie Tu *Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.
Yin ZhangDepartment of Oncology, Dazhou Central Hospital, Dazhou, Sichuan, China.
Yan ZhangDepartment of Thoracic Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Sichuan, China.
Jiasi WangDepartment of Clinical Laboratory, Dazhou Central Hospital, Dazhou, Sichuan, China.ORCID 0000-0001-8221-3015
Zhaoping ZengDepartment of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.
Jie LiDepartment of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.
Fanxin ZengDepartment of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.
Dazhou Central Hospital · CNSichuan University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Assessment of colorectal cancer (CRC) lymph node metastasis (LNM) is critical to the decision of surgery, prognosis, and therapy strategy. In this study, we aimed to develop and validate a multiple tumor marker nomogram for predicting LNM in CRC patients. Methods: A total of 674 patients who met the inclusion criteria were collected and randomly divided into primary cohort and internal test cohort at a ratio of 7:3. An external test cohort enrolled 178 CRC patients from the West China Hospital. Clinicopathologic variables were obtained from electronic medical records. The least absolute shrinkage and selection operator (LASSO) and interquartile range analysis were carried out for variable dimensionality reduction and feature selection. Multivariate logistic regression analysis was conducted to develop predictive models of LNM. The performance of the established models was evaluated by the receiver operating characteristic (ROC) curve, calibration belt, and clinical usefulness. Results: Based on minimum criteria, 18 potential features were reduced to six predictors by LASSO and interquartile range in the primary cohort. The model demonstrated good discrimination and ROC curve (AUC = 0.721 in the internal test cohort, AUC = 0.758 in the external test cohort) in LNM assessment. Good calibration was shown for the probability of CRC LNM in the internal and external test cohorts. Decision curve analysis illustrated that multi-tumor markers nomogram was clinically useful. Conclusions: The study proposed a reliable nomogram that could be efficiently and conveniently utilized to facilitate the assessment of individually-tailored LNM in patients with CRC, complementing imaging and biopsy tests.

Indexed as

Biomarkers, TumorColorectal NeoplasmsHumansLymphatic MetastasisNomogramsRetrospective StudiesBiomarkers, TumorAssessment modelColorectal cancerLymph node metastasisNomogramTumor markers

Identifiers

PMID35433129
PMCPMC9009328
OpenAlexW4223575454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.